UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intensive efforts for future antidiabetic agents

Läkartidningen, 2010-11, Vol.107 (45), p.2815-2819

Berne, Christian

2010

Volltextzugriff (PDF)

Clinical experiences with Levemir treatment

Läkartidningen, 2007, Vol.104 (1-2), p.54-54

2007

Volltextzugriff (PDF)

Insulin detemir compared with NPH insulin. No significant differences identified in the studies

Läkartidningen, 2006-05, Vol.103 (18), p.1417, 1419-1417

2006

Volltextzugriff (PDF)

Documented advantages of Lantus in comparison with NPH

Läkartidningen, 2004-10, Vol.101 (42), p.3270, 3273; author reply 3273-3270

Birgersson, Margareta Olsson

2004

Volltextzugriff (PDF)

My quality of life has increased with Lantus

Läkartidningen, 2004-09, Vol.101 (39), p.3015; discussion 3016-3015; discussion 3016

Euler, Henrikvon

2004

Volltextzugriff (PDF)

Documented advantages of insulin Lantus when compared with NPH insulin

Läkartidningen, 2004-09, Vol.101 (39), p.3014-3014

Frid, Anders

2004

Volltextzugriff (PDF)

Insulinglarin - en systematisk översikt av behandlingsstudier. Inga dokumenterade fördelar med Lantus jämfört med NPH-insulin

Läkartidningen, 2004, Vol.101 (30-31), p.7

2004

Volltextzugriff (PDF)

New insulin analogues with improved pharmacokinetics

Läkartidningen, 1989-09, Vol.86 (39), p.3268

1989

Volltextzugriff (PDF)

One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial

Diabetes care, 2009-05, Vol.32 (5), p.762-768

2009

Volltextzugriff (PDF)

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

Cochrane database of systematic reviews, 2007-04 (2), p.CD005613

2007

Volltextzugriff (PDF)

Cross-reactivity of insulin analogues with three insulin assays

Annals of clinical biochemistry, 2015-05, Vol.52 (3), p.312-318

2015

Volltextzugriff (PDF)

Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies

Acta diabetologica, 2019-12, Vol.56 (12), p.1283-1292

2019

Volltextzugriff (PDF)

Insulin analogues in type 1 diabetes mellitus: getting better all the time

Nature reviews. Endocrinology, 2017-07, Vol.13 (7), p.385-399

2017

Volltextzugriff (PDF)

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin

Pharmaceutical research, 2012-08, Vol.29 (8), p.2104-2114

2012

Volltextzugriff (PDF)

‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues

Diabetologia, 2021-05, Vol.64 (5), p.1016-1029

2021

Volltextzugriff (PDF)

Trehalose Glycopolymer Enhances Both Solution Stability and Pharmacokinetics of a Therapeutic Protein

Bioconjugate chemistry, 2017-03, Vol.28 (3), p.836-845

2017

Volltextzugriff (PDF)

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

Diabetologia, 2012-12, Vol.55 (12), p.3155-3162

2012

Volltextzugriff (PDF)

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Diabetologia, 2009-10, Vol.52 (10), p.2046-2055

2009

Volltextzugriff (PDF)

Insulin and insulin analogs as antidiabetic therapy: A perspective from clinical trials

Cell metabolism, 2021-04, Vol.33 (4), p.740-747

2021

Volltextzugriff (PDF)

Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)

Diabetes care, 2011-02, Vol.34 (2), p.256-261

2011

Volltextzugriff (PDF)

Non‐alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes

Diabetes, obesity & metabolism, 2017-11, Vol.19 (11), p.1630-1634

2017

Volltextzugriff (PDF)

Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes

Diabetes, obesity & metabolism, 2017-01, Vol.19 (1), p.3-12

2017

Volltextzugriff (PDF)

Structural Basis for the Lower Affinity of the Insulin-like Growth Factors for the Insulin Receptor

The Journal of biological chemistry, 2008-02, Vol.283 (5), p.2604-2613

2008

Volltextzugriff (PDF)

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

Diabetologia, 2009-09, Vol.52 (9), p.1732-1744

2009

Volltextzugriff (PDF)

Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes

Diabetes care, 2015-12, Vol.38 (12), p.2211-2216

2015

Volltextzugriff (PDF)

1 – 25 von 14.043

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12.746)
Mit Volltextzugriff
(11.245)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(11.433)
Life Sciences & Biomedicine
(10.838)
Humans
(8.758)
Male
(6.673)
Animals
(6.614)
Female
(5.115)
Biological And Medical Sciences
(4.272)
Endocrinology & Metabolism
(4.131)
Insulin
(3.695)
Insulin - Analogs & Derivatives
(3.593)
Rats
(3.210)
Medical Sciences
(2.991)
Middle Aged
(2.943)
Adult
(2.867)
Insulin - Metabolism
(2.550)
Diabetes
(2.484)
Diabetes Mellitus, Type 2 - Drug Therapy
(2.199)
Insulin Resistance
(2.167)
Blood Glucose - Metabolism
(2.126)
Hypoglycemic Agents - Therapeutic Use
(2.052)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(14.029)
Elektronische Zeitschriftenbibliothek (Open access)
(6.221)
Journals@Ovid Full Text
(6.023)
Ingenta
(5.671)
ScienceDirect
(2.815)
Publisher or Other Site
(2.513)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.289)
IngentaConnect Journals
(2.286)
Wiley-Blackwell Journals
(1.989)
Wiley Online Library
(1.608)
Springer Online Journals
(1.421)
Oxford Journals
(1.143)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(916)
Oxford Journals 2020 Medicine
(809)
Taylor & Francis Journals
(468)
Taylor & Francis
(445)
Taylor & Francis Current Content Access
(420)
Nature Journals Online
(286)
JSTOR
(251)
Thieme - Connect here FIRST to enable access
(237)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intensive efforts for future antidiabetic agents

Clinical experiences with Levemir treatment

Insulin detemir compared with NPH insulin. No significant differences identified in the studies

Documented advantages of Lantus in comparison with NPH

My quality of life has increased with Lantus

Documented advantages of insulin Lantus when compared with NPH insulin

Insulinglarin - en systematisk översikt av behandlingsstudier. Inga dokumenterade fördelar med Lantus jämfört med NPH-insulin

New insulin analogues with improved pharmacokinetics

One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

Cross-reactivity of insulin analogues with three insulin assays

Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies

Insulin analogues in type 1 diabetes mellitus: getting better all the time

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin

‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues

Trehalose Glycopolymer Enhances Both Solution Stability and Pharmacokinetics of a Therapeutic Protein

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Insulin and insulin analogs as antidiabetic therapy: A perspective from clinical trials

Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)

Non‐alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes

Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes

Structural Basis for the Lower Affinity of the Insulin-like Growth Factors for the Insulin Receptor

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes

Suchergebnisse filtern